Because the short interfering RNA (siRNA) widely used for studying gene functions in mammalian cells varies markedly in its gene-silencing efficacy, several siRNA design rules/guidelines have been reported recently. Analyzing the reported siRNA design guidelines from qualitative and quantitative points of views, we found that they were not always effective selection rules for many other mammalian genes. Though some rules from the guidelines are suitable for extracting effective sequences for specific genes, they might sometimes be unsuitable for selecting sequences for other genes. Since the gene-silencing efficacy depends very much on the target sequence positions selected from the target gene, we examined 860 effective siRNA sequences from 503 different mammalian cDNAs in the literature. As a result, we got many preferred and unpreferred nucleotides different from the ones used in the previous guidelines. These sequence-dependent nucleotides could be used as a more general guideline for selecting new siRNA sequences in target genes. We proposed a measure (score) for selecting effective siRNA candidates based on the positional features of specific significant nucleotides and demonstrated the effectiveness of the proposed measure compared with the recently reported other selection methods. In this paper we also discussed the elimination of ineffective siRNA sequences from target candidates and optimal GC content in siRNA sequences.
Introduction
RNA interference (RNAi) silences gene expression by introducing double-stranded RNA (dsRNA) homologous to the target mRNA, and it has been widely used for studying gene functions [4] [5] [8] [19] . The short interfering RNA (siRNA) responsible for RNA interference, however, varies markedly in its gene-silencing efficacy in mammalian genes, where the gene-silencing effectiveness depends very much on the target sequence positions (sites) selected from the target gene [6] [10] . That is, different siRNAs synthesized for various positions induce different levels of gene-silencing. This indicates that the selection of the target sequence is critical to the effectiveness of the siRNA and that we therefore need useful criteria for gene-silencing efficacy when we are designing siRNA sequences. Some of the factors related to gene-silencing efficacy that have reported by investigators studying RNAi molecular mechanisms for mRNA cleavage are the binding energy, "GC" content, point-specific nucleotides and specific motif sequences [12] [18] . Since these factors could therefore be inferred to play important roles in determining effective siRNA sequences for the target gene, several siRNA design rules/guidelines using these factors have reported [1] [2] [11] [15] [24] . Although a comparative analysis of them has been reported recently [14] [16] [17] [20] [23] , there is no consideration of the most important nucleotide features. Furthermore, although there is an off-target regulation risk in RNAi, when we use gene-silencing for studying gene functions we have to first somehow select high-potential siRNA candidates and eliminate possible off-target candidates.
We therefore examined three typical recently reported guidelines for siRNA efficacy [1] [15] [24] from the points of nucleotide occurrences for effective siRNAs and found few consistencies among them, possibly because they are based on sequence analyses for only a few target genes. Evaluating these guidelines qualitatively and quantitatively, we concluded that they are not always useful for selecting highly effective siRNA sequences for genes other than the target genes. Although there are other rules for siRNA designs, they seem to be not so clear factors for effective siRNAs [16] [17] [23] . What we need is a more general guideline for selecting the siRNA target sequence. Hypothesizing that the nucleotide occurrence trends are important, we examined previously reported effective siRNA sequences for clear tendencies in nucleotide occurrence. We examined 860 effective siRNA target sequences from 503 different mammalian cDNAs in the literature in the PubMed database [3] [9] [13] . Analyzing these sequences statistically, we found important features other than the ones used in the previous guidelines [1] [11] [15] [24] . This paper will first clarify the effectiveness of previous guidelines qualitatively and quantitatively. It will then describe positional features of specific significant nucleotides found by analyzing 860 sequences and will propose a measure (score) for selecting effective siRNA candidates based on the obtained positional features of significant nucleotides and will evaluate the effectiveness of the proposed measure compared with the other selection methods using scores [17] . It will finally discuss the elimination of ineffective sequences from target candidates and the optimal "GC" content of siRNA sequences.
Materials and Methods

Relations between individual guidelines and the effective/ineffective siRNA sequences
Individual guidelines are summarized in Figure 1 . Guideline 1 (G1) specifies four preferred nucleotides: I (A at position 3), II (T at position 10), III (A or C or T at position 13) and IV (A or T at position 19) [15] . As the preferred nucleotides should occur at these positions with higher probabilities than other nucleotides, we compared their occurrence probabilities there with their average occurrence probabilities in the effective and ineffective target sequence populations. We carried out similar comparisons for the following Guidelines 2 and 3. Guideline 2 (G2) specifies two preferred nucleotides, I (G or C at position 1) and II (A or T at position 19) and two unpreferred nucleotides, III (A or T at position 1) and IV (G or C at position 19) [24] . Guideline 3 (G3) specifies five preferred nucleotides -I (G or C at position 1), II (A at position 6), III (T at position 13), IV (C at position 16) and V (A or T at position 19) -and specifies three unpreferred nucleotides: VI (T at position 1), VII (T at position 10) and VIII (G at position 19) [1] .
As G1, G2 and G3 are respectively based on the analyses of two genes (firefly luciferase and human cyclophilin B), six genes (firefly luciferase (PRL-TK), Vimentin, Oct 4, EGFP, ECFP, and DsRed) and four genes (human tissue factor (hTF), murine tissue factor (mTF), human protein serine kinase H1 (PSK) and human C-Src tyrosine kinase (CSK)), for simplicity these genes are symbolized as MG1-1 (firefly luciferase), MG1-2 (human cyclophilin B), MG2 (six genes) and MG3 (four genes) throughout this paper. Effective and ineffective siRNA sequences for the symbolized genes were selected from the literature in the following way [ To get a large number of effective siRNA sequences, we collected target sequences from published references in the PubMed database. As a result, we obtained 860 effective siRNA sequences (more than 70% gene-silencing) from 503 different cDNAs. The numbers of individual nucleotide occurrences at each of positions from 1 to 19 of MG1 -1, MG1-2, MG2, MG3 and 503  gene effective sequences are respectively listed in Tables 1A, 1B, 1C, 1D and 1E . 
Effectiveness definition for individual guidelines
As G1, G2 and G3 specify preferred/effective and unpreferred/ineffective nucleotides for selecting effective gene-silencing sequences, it might be possible to estimate the effectiveness of the individual guidelines by comparing the occurrence probability of nucleotides specified by the guidelines with the corresponding nucleotide average probability in their sequence populations. That is, their effectiveness can be evaluated by comparing the probability of the nucleotides assigned by individual guidelines with the occurrence probabilities of the corresponding nucleotides averaged over the entire target sequence population.
For this evaluation we used the ratio ER defined as follows:
where NR p is the nucleotide probability assigned by the guideline at position p (e.g., . This implies that the nucleotide A at position 3 indicates the average frequency level although it is specified as the preferred nucleotide by the guideline. The ratio ER therefore indicates the effectiveness of the individual guideline. If the ER for the preferred/effective nucleotide is markedly larger than 1, the nucleotide specified by that guideline is effective for other genes. And if the ER for the specified nucleotide is markedly lower than 1, the guideline is ineffective for other genes. A converse relation applies to the ERs for the unpreferred/ineffective nucleotides: the guideline is ineffective for other genes when the ER > 1 and is effective when the ER < 1.
Although it is generally difficult to determine the exact ER needed to distinguish effective guidelines from ineffective guidelines, we regarded ER > 1.25 to indicate an effective nucleotide and ER < 0.75 to indicate an ineffective nucleotide. The reason for choosing an ER at least 25% greater than 1 as a preferred value and an ER at least 25% less than 1 as an unpreferred one is that we expected these values to provide 99% statistical significance for the population of more than 300 sequences. Similarly, for the unpreferred/ineffective nucleotide, we regarded ER < 0.75 as effective and ER > 1.25 as ineffective.
Statistical significance analysis
If a gene-silencing phenomenon depends on siRNA sequences, nucleotide occurrence features should be evident when a large number of effective target sequences are analysed statistically. That is, it is possible to test the significance of each nucleotide at individual positions (i.e., 1 to 19) on the basis of the occurrence probabilities of each nucleotide at individual positions and in the entire target sequence population. We used the following significance testing to clarify individual nucleotide positional dependencies:
where P a is the probability of each nucleotide occurring at the individual sequence sites (i.e., positions 1 to 19), P b is the occurrence probability of each nucleotide averaged over the entire target sequence population, P is P a and P b arithmetic means, n a is the number of nucleotides at individual positions (sites) and n b is the total number of nucleotides in all positions (sites) [21] [22].
Suppose, for example, that we have 200 effective siRNA sequences. If the occurrence probability of the nucleotide G at position 7 is 0.35 (70/200) and the occurrence probability of G in the entire target sequence population is 0.28 (1064/(200×19)), the 95% significance probability of the nucleotide G at position 7 would be indicated by a z value of 2.14.
Statistical significant nucleotide selection
As the two-sided statistical test has two types of significance values, higher (upper) and lower levels of significance, they are expressed as follows:
Higher-significance nucleotide ( v : 95 -significance probability is 95% (level of significance = 0.05), 99 -significance probability is 99% (level of significance = 0.01), p : nucleotide position (site) ( i.e., 1-19).
Results and Discussion
Analysis I: Qualitative analysis of three guidelines
To use RNAi as a biological tool for mammalian cell experiments, we first need to identify target sequences causing gene degradation. They have so far been identified by using a trail-and-error method [7] , but siRNAs extracted from different regions of the same gene have varied remarkably in their effectiveness. The difficulty of using the trail-and-error method to select target sequences causing gene silencing increases when the coding regions are long, as they are in mammalian cells. This is because the larger the number of candidates becomes, the more difficult it is to get gene-silencing candidates. What is a good guideline for selecting gene-silencing siRNA? It is one that is effective for selecting siRNA sequences causing gene degradation and that can be applied for many genes. To determine the effectiveness of the recent reported guidelines, we first clarified the relations between them from a qualitative viewpoint and then quantitatively evaluated their effectiveness for other genes.
From Figure 1 we obtained the following consistencies among the guidelines reported by Reynolds et al., and Ui-tei et al. and Amarzguioui & Prydz [22] . 1) Consistency among three guidelines (G1, G2 and G3): A or T effective at position 19 2) Consistency between pairs of guidelines (G1 and G3, G2 and G3):
T effective at position 13 (G1 and G3) G or C effective at position 1 (G2 and G3) T ineffective at position 1 and G ineffective at position 19 (G2 and G3) Because we found only these few consistencies, we thought it would be difficult use these guidelines to select effective target sequences. If only these few nucleotide consistencies were used for selecting target sequences, many sequence candidates would be extracted from the target genes and it would be hard to select a few final candidates for synthesizing siRNAs.
Analysis II: Quantitative individual guideline effectiveness for other genes
We first examined the effectiveness of the individual guidelines (G1, G2 and G3) for the reported genes (see Materials and Methods). If G1, G2 and G3 were effective for selecting effective siRNA sequences for other genes, the preferred and unpreferred nucleotides for effective gene-silencing sequences would show the similar occurrence tendencies with each of the guidelines. This can be determined by analyzing the ER values obtained when the individual guidelines are applied for other genes.
Guideline 1 (G1) effectiveness for selecting sequences effective for other genes
In G1 there are four preferred nucleotides ( I, II, III and IV) (see Materials and Mehtods). If G1 were applicable to designing siRNAs for other genes (MG2 and MG3), the four nucleotides in the effective sequences would occur at the specified sites more often than they would occur elsewhere. That is, if G1 were effective for the other genes, the four nucleotides should be higher than the G1 property in Figure 2 (A). The relations between G1 and the reported genes MG2 and MG3 are shown in Figure 2 (A), which shows that G1 indicates many reverse tendencies (under the G1 property) for effective sequences in other genes and only nucleotide IV demonstrates G1 effectiveness for MG2 and MG3. In other words, it could be inferred that it is difficult to use G1 for selecting sequences effective in other genes. 
Guideline 2 (G2) effectiveness for selecting sequences effective for other genes
In G2 there are two preferred nucleotides ( I and II ) and two unpreferred nucleotides ( III and IV) (see Materials and Methods). If G2 were effective for other genes, the same occurrence tendencies would be expected there. That is, the nucleotides I and II should be higher than the G2 property, the nucleotides III and IV should be lower than the G2 property in Figure 2 relations between G2 and the reported genes MG1-1, MG1-2 and MG3 are shown in Figure 2 (B). Overall, it could be inferred that G2 has similar tendencies for the other gene effective sequences except MG1-1. However, as both the nucleotides I and III are located at position 1 and both the nucleotides II and IV are located at position 19, there are many possible candidate sequences between positions 2 and 18. So even though candidate sequences satisfy G2, there might be many alternative sequences. This means that the selection of effective sequences becomes a time-consuming task.
Guideline 3 (G3) effectiveness for selecting sequences effective for other genes
In G3 there are five preferred nucleotides (I, II, III, IV and V) and three unpreferred nucleotides (VI, VII and VIII) (see Materials and Methods). If G3 were effective for other genes, the eight nucleotides would show the same occurrence tendencies there. That is, the nucleotides I to V should be higher than the G3 property and the nucleotides VI to VIII should be lower than the G3 property in Figure 2(C) . The relations between G3 and MG1-1, MG1-2 and MG2 are shown in Figure 2 (C). Overall, G3 has similar tendencies for the other genes except MG1-1.
We then analysed the individual guideline effectiveness for 860 effective siRNA sequences from 503 different mammalian cDNAs in the literature.
Individual guideline (G1, G2 and G3) effectiveness for selected effective siRNA sequences in 503 genes
ERs indicating the degree of G1 effectiveness for 860 sequences from 503 cDNAs are also shown in Figure 2(A) . As the range of ER for 860 sequences is from 1.02 to 1.19, there is no nucleotide for which ER > 1.25. The results thus show that G1 provides no effective guidance for selecting gene-silencing sequences for many mammalian genes.
ERs indicating G2 and G3 effectiveness for 860 sequences are respectively shown in Figures  2(B) and 2(C). G2 shows that the nucleotides I and III are effective indications for 860 sequences. As both I and III are located at position 1, however, provides effective guidance only at position 1. G3 also indicates the same tendency. That is, the nucleotides I (ER=1.46) and VI (ER=0.5) provide effective guidance only at position 1. As G1 is not effective and G2 and G3 are effective only at position 1 for 860 sequences from 503 cDNAs, these three guidelines may not be effective for many mammalian genes.
Individual guideline efficacies
For clarity we use positive (+) and negative (-) indications of positional features for the individual guidelines G1, G2 and G3 shown in Figure 3 . Although G1 has two nucleotides showing positive indications (i.e., III for MG2 and IV for MG2 and MG3), there are two nucleotides showing negative indications (i.e., II for MG3 and I for MG2 and MG3). In addition, there is no G1 tendency for 503 genes. This indicates that G1 is partially useful for specific genes. On the other hand, as G2 has four nucleotides showing positive tendencies (i.e., the nucleotides I, II, III and IV for MG1-2 and MG3, and II and IV for MG1-1, and I and III for 503 genes), it indicates effective tendencies for MG1-2 and MG3. As the effective nucleotides I and III for 503 genes are located at position 1, however, there is no effective nucleotide indicated for any of the other positions. This might imply that there are many candidates satisfying the nucleotide condition specified at position 1. In contrast, as G3 has seven nucleotides showing positive tendencies (i.e., the nucleotides V and VIII for MG1-1, I to VI and VIII for MG1-2, I, III, V, VI and VIII for MG2, I, II, VI and VIII for 503 genes), it provides effective indications for MG1-2 and MG2 but ineffective indications for MG1-1. However, although G3 has four effective nucleotides (4/8) for 503 genes, only two ( I and VI) satisfies with G3 property and their positions are located at 1. So it might be possible to select many candidates satisfying these conditions. It may therefore be hard to determine whether they are effective gene-silencing candidates. : distinct reverse tendency "--". 3(A) Guideline G1 effectiveness. 3(B) Guideline G2 effectiveness. 3(C) Guideline G3 effectiveness.
3(A)
I
siRNA sequence selection problems using the previous guidelines
Our qualitative and quantitative analyses revealed that G1, G2 and G3 are not always effective selection rules for other mammalian genes. In other words, though some rules from the guidelines are suitable for getting effective sequences for specific genes, they might sometimes be unsuitable for selecting sequences for other genes. Since the individual guidelines G1, G2 and G3 are based on the analyses of specific genes, it could be inferred that they are not always effective for many other genes. Therefore if these guidelines were used to select sequence candidates for other mammalian genes, many sequences might be selected as candidates. This is because there are mostly long coding regions in mammalian genes but there are only a few consistencies among G1, G2 and G3. As a result, many candidate sequences might be selected. Experimentally evaluating whether the selected sequences provide effective gene degradation, however, is a costly and time-consuming task.
The proposed measure based on the positional features of significant nucleotides
Since it could be inferred that the previous guideline problems were based on specific gene analyses, we examined whether there are nucleotide occurrence specificities for many effective siRNA sequences reported in the literature (see Materials and Methods).
We analysed 860 sequences listed in Table 1E by using Equation (2) and obtained many higher-significance and lower-significance nucleotides shown in Table 2 . They are mostly different from the previous reported nucleotides obtained by using G1, G2 and G3. Table 2 . Higher-significance and lower-significance nucleotides and their static values.
Gene silencing measure (score) definition
A target siRNA sequence including many higher-significance nucleotides and a few lower-significance nucleotides could be inferred to become a highly effective gene-silencer. A measure (priority score S) based on this idea is therefore defined in the following way.
where a and b are weighting factors for higher and lower scores, normally a=b=1. LN are respectively higher-significance and lower-significance nucleotides (see Materials and Methods). Equation (3) shows that the larger S becomes, the greater the likelihood that the sequence is effective for gene-silencing.
Effectiveness of the proposed score method
The purpose of the score setting is to indicate the sequence priority for selecting new siRNA candidates. This is because it is necessary to select several of the highest-ranked sequences as target sequences for dsRNA syntheses. From this point of view, we evaluated the effectiveness of the proposed score for effective and ineffective siRNA sequences of MG1-1, MG1-2, MG2 and MG3 by using equation (3) and Table 2 . Since there were ups and downs in the computed scores of the individual sequence classes, we calculated the averages for them. The average scores of the effective sequences for MG1-1, MG1-2, MG2 and MG3 were respectively 2.2, 8.8, 13.2 and 5.9, whereas those of the ineffective sequences were -1.5, -9.5, -14.3 and -3.8. These scores therefore reveal that the proposed method might be useful for selections of effective siRNA candidates. We also examined the average scores obtained by the previously reported score methods of Reynolds et al., Ui-Tei et al., Amarzguioui and Prydz, and Hsieh et al. [17] . The relative relations between scores of the previous methods and those of the proposed method are shown in Figure 4 . The results indicate that the previous methods are not always clear correspondences between the scores and the effective and ineffective siRNA sequences. 
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example, show positive values for both effective and ineffective siRNAs of MG1-1, MG1-2 and MG3, and don't indicate distinct score differences between the effective and ineffective siRNAs. In addition, although the methods of Ui-Tei et al. and Amarzguioui and Prydz indicate the correspondences between the individual average scores and the effective and ineffective siRNAs for MG1-2, MG2 and MG3, the relative score differences between the effective and ineffective siRNAs are not so big as shown in Figure 4 . In addition, the maximum and minimum score ranges of their methods are respectively from 2 to -2 and from 8 to -2. [17] . These score ranges imply that the restricted discrete scores might be assigned to the candidate sequences. For example, the method of Ui-Tei et al. may assign five kinds of scores, i.e., (2, 1, 0, -1, -2) to the candidate sequences. This indicates that there might be many same score sequences and the difficulty of selecting several candidates. Therefore, these previous method results imply that it is difficult to assign the priority of new siRNA candidates according to the obtained scores. On the other hand, as the range of the proposed score is 46.8 to -43.7 from Table 2 , it is easy to distinguish the priority for the candidate sequences. The proposed scores, for example, indicate clear correspondences for the effective and ineffective siRNAs of MG1-2, MG2 and MG3. This therefore implies that the proposed score can easily be used for selecting high-potential siRNA candidates. 
Individual guideline effectiveness for ineffective siRNA sequences
If G1, G2 and G3 were effective for eliminating ineffective siRNA sequences for other genes, with each of the guidelines the individual preferred and unpreferred nucleotides for ineffective gene-silencing sequences would show the reverse occurrence tendencies. That is, the preferred nucleotide ERs would be lower than 0.75 for the ineffective sequences, whereas the unpreferred nucleotide ERs would be higher than 1.25 for them.
G1 effectiveness for eliminating ineffective sequences for other genes
In ineffective sequences for other genes, the nucleotides I, II, III and IV should be have a distinctly lower probability of occurring at the specified sites than other nucleotides have. If G1 indicates the same tendency for other genes, the same occurrence phenomena are expected (i.e., ERs < 0.75). That is, the nucleotides I to IV should be lower than the G1 property in Figure 5(A) . The relations between G1 and MG2 and MG3 are shown in Figure 5 Takasaki ratio of nucleotide ER<0.75 for MG2 is 2/4 (I and IV), whereas that for MG3 is zero. It could therefore be inferred that G1 is not always useful for eliminating ineffective siRNA sequences.
Effectiveness of G2 and G3 for eliminating ineffective sequences for other genes
If G2 indicates the same tendency for other genes, ERs for the preferred nucleotides I and II are expected to be lower than 0.75 and ERs for the unpreferred nucleotides III and IV are expected to be higher than 1.25. That is, the nucleotides I and II should be lower than the G2 property and the nucleotides III and IV should be higher than the G2 property in Figure 5(B) . The relations between G2 and MG1-1, MG1-2 and MG3 are shown in Figure 5(B) . The results show that G2 provides a good guideline for MG1-2 -that is, the ERs for I and II are less than 0.75 and the ERs for III and IV are higher than 1.25 -whereas it show distinct reverse tendencies for MG1-1 and slightly reverse tendencies for MG3. This means that G2 is not always useful for eliminating ineffective sequences.
G3 has five preferred nucleotides ( I to V) and three unpreferred nucleotides (VI, VII and VIII), and the ERs for the preferred nucleotides are expected to be lower than 0.75 and the ERs for the unpreferred nucleotides should be higher than 1.25. That is, the nucleotides I to V should be lower than the G3 property and the nucleotides VI to VIII should be higher than the G3 property in Figure  5 (C). The relations between G3 and MG1-1, MG1-2 and MG2 are shown in Figure 5 (C). The results show that G3 provides a relatively good guideline for MG1-2 and MG2 ( I, II, V, VI and VIII for MG1-2 and I, III, V, VII and VIII for MG2), whereas it shows a negative guideline for MG1-1 (only VII is higher than 1.25). 
Optimal GC content
We examined the GC content of effective and ineffective siRNA sequences for reported genes. The distribution of GC content for the sets of reported genes is listed in Table 3 . The results indicate that there is no big difference between effective and ineffective sequences. It could therefore be inferred that gene-silencing effectiveness does not depend on GC content. As the average GC content for 860 effective sequences is 50.8% with a standard deviation of 8.9%, this value could be used as a guideline. 
Conclusions
Analyzing the reported siRNA design guidelines from qualitative and quantitative points of views, we found that they were not always effective selection rules for many other mammalian genes. Though some rules from the guidelines are suitable for extracting effective sequences for specific genes, they might sometimes be unsuitable for selecting sequences for other genes. Since the gene-silencing efficacy depends very much on the target sequence positions selected from the target gene, we examined 860 effective siRNA sequences from 503 different mammalian cDNAs in the literature. As a result, we got many preferred and unpreferred nucleotides different from the ones used in the previous guidelines. We proposed the gene silencing measure based on the positional features of significant nucleotides and demonstrated the effectiveness of the proposed measure compared with the recently reported other scoring methods. In this paper we also discussed the elimination of ineffective siRNA sequences from target candidates and optimal GC content in siRNA sequences.
